Deep Track Capital »

Point Biopharma Global shares owned by Deep Track Capital

Quarter-by-quarter ownership of Point Biopharma Global shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Point Biopharma Global

Tip: Access up to 7 years of quarterly data

All positions including Point Biopharma Global held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Point Biopharma Global by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $19M 2.8M 6.67
2023-06-30 $25M 2.8M 9.06
2023-03-31 $17M 2.3M 7.27

More positions owned by Deep Track Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Intra Cellular Therapies (ITCI)
Ionis Pharmaceuticals (IONS)
Guardant Health (GH)
Immunovant (IMVT)
Alkermes SHS (ALKS)
Dynavax Technologies Corp Com New (DVAX)
Structure Therapeutics Sponsored Ads (GPCR)
Pliant Therapeutics (PLRX)
Springworks Therapeutics (SWTX)
Axsome Therapeutics (AXSM)
Bicycle Therapeutics Sponsored Ads (BCYC)
Travere Therapeutics (TVTX)
Intellia Therapeutics (NTLA)

View all positions for Deep Track Capital

Top funds holding Point Biopharma Global

Jet Capital Investors

View all funds holding Point Biopharma Global